Gemeinsame Jahrestagung der ÖGH und ÖGN. 3. bis 5. Oktober 2019, Gmunden, Abstracts Journal für Hypertonie - Austrian Journal of Hypertension 2019; 23 (2): 42-48 Volltext (PDF) Übersicht
| ||||||||
Abbildung 4: Plasma concentrations Prausmueller S et al. Plasma concentrations of pathophysiologically relevant vasoactive peptides in stable HFrEF patients according to RAS activation. Tukey boxplots between the low, medium and high renin HFrEF patients is shown for A) copeptin (CT-proAVP), B. bioactive adrenomedullin (bio-ADM) and C. big-endothelin1 (bigET-1). P-values are indicated for the comparison by the Kruskal-Wallis-test. |
![]()
Abbildung 4: Plasma concentrations
Prausmueller S et al. Plasma concentrations of pathophysiologically relevant vasoactive peptides in stable HFrEF patients according to RAS activation. Tukey boxplots between the low, medium and high renin HFrEF patients is shown for A) copeptin (CT-proAVP), B. bioactive adrenomedullin (bio-ADM) and C. big-endothelin1 (bigET-1). P-values are indicated for the comparison by the Kruskal-Wallis-test. |